跳至主要内容
临床试验/NCT01518114
NCT01518114Unknown不适用

Exercise Training in Patients With Hypertrophic Cardiomyopathy

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Functional capacity improvement as determined by the degree of percent change in VO2 MAX following structured exercise rehabilitation

研究概览

简要总结

Exercise training (ET) is highly beneficial in heart failure patients and has been suggested to confer significant symptomatic and functional improvements in patients with diastolic dysfunction. Accordingly, the aim of this study was to examine the safety, feasibility of a structured ET program in symptomatic HCM patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hypertrophic Cardiomyopathy
  • Maximal left ventricular wall thickness > 20 mm

排除标准

  • Severe non-cardiac limitations of functional capacity such as neurological illness, lung disease, peripheral vascular or orthopedic problem, etc.
  • Patients state post resuscitation for malignant ventricular arrhythmia.
  • History of effort induced syncope, complex ventricular arrhythmia or atrial fibrillation.
  • An exercise-induced decrease in blood pressure
  • Severe left ventricular outflow obstruction defined as resting outflow gradient > 50 mmHg on maximal therapy
  • Atrial fibrillation with a poorly controlled ventricular response
  • Advanced hypokinetic stage of HCM defined as LVEF < 40%
  • Congestive heart failure of angina FC IV according to NYHA or CCS respectively.

结局指标

主要结局

Functional capacity improvement as determined by the degree of percent change in VO2 MAX following structured exercise rehabilitation

时间窗: 6 months

End point to be assessed by cardiopulmonary testing are pre- and post exercise training improvement as expressed by the changes in : VO2 MAX, exercise duration, duration to ventilatory threshold(VT).

Safety of exercise training in patients with symptomatic hypertrophic cardiomyopathy

时间窗: 12 months

Safety endpoonts: 1) Clinicaly significant arrhythmia during exercise training 2)MACE during follow-up period (ACS, Stroke or Death) 3)Exercise Related Injury 4) Episodes of syncope

次要结局

  • Secondary Endpoints:(12 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Michael Arad

MD

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验